WALTHAM, Mass.--Genome Therapeutics here announced the extension of its $43.5 million collaboration with Schering-Plough to identify and develop novel antiinfectives for drug-resistant bacteria. The expanded agreement will carry the alliance at least through March 31, 2000. The two companies also forged a $67 million alliance in December, 1996, to develop novel therapeutics for asthma, and a $33 million antifungal collaboration in September, 1997.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.